全文获取类型
收费全文 | 385篇 |
免费 | 13篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 36篇 |
妇产科学 | 1篇 |
基础医学 | 15篇 |
口腔科学 | 9篇 |
临床医学 | 36篇 |
内科学 | 50篇 |
皮肤病学 | 8篇 |
神经病学 | 4篇 |
特种医学 | 119篇 |
外科学 | 24篇 |
综合类 | 29篇 |
预防医学 | 10篇 |
眼科学 | 27篇 |
药学 | 25篇 |
肿瘤学 | 26篇 |
出版年
2023年 | 1篇 |
2020年 | 1篇 |
2019年 | 2篇 |
2018年 | 5篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 7篇 |
2014年 | 6篇 |
2013年 | 10篇 |
2012年 | 2篇 |
2011年 | 5篇 |
2010年 | 9篇 |
2009年 | 12篇 |
2008年 | 10篇 |
2007年 | 21篇 |
2006年 | 25篇 |
2005年 | 4篇 |
2004年 | 10篇 |
2003年 | 4篇 |
2002年 | 5篇 |
2001年 | 15篇 |
2000年 | 4篇 |
1999年 | 6篇 |
1998年 | 33篇 |
1997年 | 21篇 |
1996年 | 26篇 |
1995年 | 22篇 |
1994年 | 19篇 |
1993年 | 22篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 9篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 11篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 13篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1975年 | 1篇 |
排序方式: 共有420条查询结果,搜索用时 31 毫秒
91.
Aim : Fabry disease is an X-linked inborn error of glycosphingolipid metabolism due to the deficient activity of α-galactosidase A, a lysosomal enzyme. It is a multisystem disorder characterized by progressive renal insufficiency, with added morbidity from cardio- and cerebrovascular involvement. The recent availability of genetically engineered enzyme offers an effective targeted treatment approach, but also emphasizes the need for surrogate markers to delineate organ damage and monitor the efficacy of enzyme replacement therapy (ERT). Methods : Multiple endothelial factors and plasma homocysteine concentrations were investigated in 12 consecutive hemizygous males with classic Fabry disease and 15 controls as part of an exhaustive baseline evaluation prior to ERT. Results : Compared with the controls, plasma concentrations of homocysteine were significantly ( p > 0.01) higher in patients with Fabry disease in the absence of chronic renal failure or vitamin deficiency. Plasma concentrations of vascular cell adhesion molecule-1 were also significantly ( p > 0.05) higher in the patients, and there was a trend for decreased endothelin-1 levels. No difference was found in serum intercellular adhesion molecule-1, plasma P-selectin, serum E-selectin and plasma thrombomodulin between the patients and controls.
Conclusions : The results do not reveal measurable evidence for endothelial and leukocyte activation that could reliably serve as surrogate markers for routine monitoring of the efficacy of ERT in patients with Fabry disease. While the exact origin and clinical significance of hyperhomocysteinaemia in Fabry disease remains to be studied in a larger cohort of patients carefully monitored for their concurrent medications, especially carbamazepine, we suggest that patients may benefit from folic acid or multivitamin therapy to treat this additional vascular risk factor, when present. 相似文献
Conclusions : The results do not reveal measurable evidence for endothelial and leukocyte activation that could reliably serve as surrogate markers for routine monitoring of the efficacy of ERT in patients with Fabry disease. While the exact origin and clinical significance of hyperhomocysteinaemia in Fabry disease remains to be studied in a larger cohort of patients carefully monitored for their concurrent medications, especially carbamazepine, we suggest that patients may benefit from folic acid or multivitamin therapy to treat this additional vascular risk factor, when present. 相似文献
92.
CF Poets VA Stebbens JR Alexander WA Arrowsmith SAW Salfield DP Southall 《Acta paediatrica (Oslo, Norway : 1992)》1992,81(6-7):536-541
Nineteen infants who were graduates from special care baby units underwent two overnight tape recordings of oxygen saturation (SaO2) and breathing movements; one during an upper (n = 12) or lower (n = 7) respiratory tract infection and the other when free of infection. Baseline SaO2 was lower during infection (median 99.6 vs 100%, p less than 0.01), with four patients having values (84.3-95.5%) below the normal lower limit for full-term infants (97%). The median number of apnoeic pauses was also lower during respiratory tract infection (4.7 vs 15.7/h, p less than 0.02). The median number of episodic desaturations (SaO2 less than or equal to 80%) did not change significantly (1.3 vs 1.9/h, p greater than 0.05), with the exception of one patient who had extremely increased values during infection for both apnoeic pauses (63/h) and desaturations (112/h). No infant, however, was considered clinically hypoxaemic. Clinically unsuspected hypoxaemia may thus occur during respiratory tract infection in a proportion of infants graduating from special care baby units. Such hypoxaemia may have potentially deleterious effects. 相似文献
93.
94.
95.
骨形态发生蛋白基因治疗骨缺损 总被引:2,自引:2,他引:2
目的:总结骨形态发生蛋白在骨组织工程基因治疗骨缺损中的进展。资料来源:应用计算机检索PubMed数据库1990-01/2007-01相关骨形态发生蛋白基因治疗骨缺损方面的文献,检索词"BMP,tissue engineering,gene therapy,bone defect",限定文献语言种类为English。资料选择:选取包括骨形态发生蛋白基因治疗骨缺损的文献,阅读全部文章的文题和大部分文章的摘要。纳入标准:文章所述涉及骨形态发生蛋白及其基因治疗骨缺损。排除标准:重复性研究和Meta分析类文章。资料提炼:共检索到99篇关于骨形态发生蛋白及基因治疗骨缺损的文献,最终纳入30篇符合标准的文献。资料综合:骨组织工程是组织工程学的重要组成部分,它是指利用组织工程学进行骨组织缺损的修复或重建,包括种子细胞、特定的细胞因子和载体。骨形态发生蛋白是一种疏水性酸性蛋白质,在临床实践中,已证实其能促进骨愈合,被认为是目前最强有力的一种骨诱导因子。基因治疗在许多方面都代表了一种增进骨再生方法的理念。其允许特异的基因产物转移至精确的解剖学部位。运用骨形态发生蛋白基因于骨组织工程领域以治疗骨缺损是目前新的热点。骨组织中的骨形态发生蛋白以及骨形态发生蛋白的表达和功能由于他们显著的生物学作用而被长时间的研究。结论:应用骨形态发生蛋白基因疗法可以成功诱导骨和软骨的发生,为骨缺损的治疗开辟了新的解决途径。 相似文献
96.
SUMMARY The trend towards day-case procedures is growing, as a consequence not only of improved medical care but the increasing importance of economic considerations in today's healthcare environment. In the largest worldwide study to date to assess the safety of day-case adenotonsillectomy, we reviewed the records of 4386 patients at the otolaryngology department of the Bradford Royal Infirmary. We found a reactionary haemorrhage rate of 0.57%. All patients who underwent surgery in the morning session had presented with haemorrhage and returned to the operating theatre before the end of the afternoon session. We discuss the implications of these findings, and consider that with careful monitoring day-case tonsillectomy and/or adenoidectomy may safely be introduced. 相似文献
97.
98.
Patients who develop inflammatory polyarthritis (IP) after immunization are clinically indistinguishable from other patients with IP 总被引:2,自引:1,他引:2
Harrison BJ; Thomson W; Pepper L; Ollier WE; Chakravarty K; Barrett EM; Silman AJ; Symmons DP 《Rheumatology (Oxford, England)》1997,36(3):366-369
Musculoskeletal symptoms may occur following various types of immunization,
and it has also been suggested that, like infection, immunization may act
as a trigger for rheumatoid arthritis (RA). A total of 48 of 898 (5.3%)
patients with early inflammatory polyarthritis (IP) referred to the Norfolk
Arthritis Register reported an immunization in the 6 weeks prior to symptom
onset. There were no important clinical or demographic differences between
the 48 immunized patients and 185 consecutive patients who did not report
prior immunization. In addition, the frequencies of HLA-DRB1*01. *04 and
the shared epitope in 33 of the immunized patients were similar to those in
the 185 non-immunized patients and to those in 136 healthy controls.
Further results from a case-control study suggest that the rate of
immunization is higher amongst cases (5.5%) than age- and sex-matched
controls (2.8%). In a small number of susceptible individuals, immunization
may thus act as a trigger for RA.
相似文献
99.
Goss GD; Wittwer MA; Bezwoda WR; Herman J; Rabson A; Seymour L; Derman DP; Mendelow B 《Blood》1985,66(5):1043-1046
Bone marrow transplantation for severe idiopathic aplastic anemia was undertaken in a patient, using his monozygotic twin brother as the donor. In spite of the use of syngeneic bone marrow, failure of engraftment occurred on two occasions. In vitro studies demonstrated that natural killer (NK) cells from the recipient markedly inhibited the growth of donor bone marrow granulocyte progenitor cells. On a third attempt, successful bone marrow engraftment was achieved following high-dose cyclophosphamide, which has previously been shown to be inhibitory to NK cells. We conclude that NK cell activity may play an important role in bone marrow failure as well as being responsible for at least some cases of aplastic anemia. 相似文献
100.
Szilvassy SJ; Weller KP; Lin W; Sharma AK; Ho AS; Tsukamoto A; Hoffman R; Leiby KR; Gearing DP 《Blood》1996,87(11):4618-4628
Attempts to maintain or expand primitive hematopoietic stem cells in vitro without the concomitant loss of their differentiative and proliferative potential in vivo have largely been unsuccessful. To investigate this problem, we compared the ability of three cloned bone marrow (BM) stromal cell lines to support the growth of primitive Thy- 1lo Sca-1+H-2Khi cells isolated by fluorescence-activated cell sorting from the BM of Ly-5.2 mice treated 1 day previously with 5-fluo- rouracil. Sorted cells were highly enriched in cobblestone area-forming cells (CAFC), but their frequency was dependent on the stromal cell lines used in this assay (1 per 45 cells on SyS-1; 1 per 97 cells on PA6). In the presence of recombinant leukemia inhibitory factor (LIF), CAFC cloning efficiency was increased to 1 per 8 cells on SyS-1 and 1 per 11 cells on PA6, thus showing the high clonogenicity of this primitive stem cell population. More primitive stem cells with competitive repopulating potential were measured by injecting the sorted cells into lethally irradiated Ly-5.1 mice together with 10(5) radioprotective Ly-5.1 BM cells whose long-term repopulating ability has been "compromised" by two previous cycles of marrow transplantation and regeneration. Donor-derived lymphocytes and granulocytes were detected in 66% of animals injected with 50 sorted cells. To quantitate the maintenance of competitive repopulating units (CRU) by stromal cells, sorted cells were transplanted at limiting dilution before and after being cultured for 2 weeks on adherent layers of SyS-1, PA6, or S17 cells. CRU represented 1 per 55 freshly sorted cells. CRU could be recovered from cocultures supported by all three stromal cell lines, but their numbers were approximately-sevenfold less than on day 0. In contrast, the addition of LIF to stromal cultures improved CRU survival by 2.5-fold on S17 and PA6 cells (approximately two-fold to threefold decline), and enabled their maintenance on SyS-1. LIF appeared to act indirectly, because alone it did not support the proliferation of Thy- 1lo Sca-1+H-2Khi cells in stroma-free cultures. Polymerase chain reaction (RT-PCR) analysis revealed that Interleukin-1beta (IL-1 beta) IL-2, IL-6, granulocyte-colony stimulating factor, granulocyte macrophage-colony stimulating factor, transforming growth factors, LIF, and Steel Factor (SLF) mRNAs were upregulated in SyS-1 within 1 to 6 hours of LIF-stimulation. To determine if increased expression of SLF by LIF-stimulated SyS-1 cells could account for their capacity to support stem cells, sorted calls were cocultured on simian CV-E cells that were transfected with an expression vector encoding membrane-bound SLF, or supplemented with soluble SLF. In both cases, SLF synergized with IL-6 produced endogenously by CV-E cells enabling CAFC growth equivalent to that on LIF-stimulated SyS-1. CAFC development on LIF- stimulated SyS-1 could also be completely abrogated by an anti-SLF antibody. These data provide evidence for a role of LIF in the support of long-term repopulating stem cells by indirectly promoting cytokine expression by BM stroma. Furthermore, we have used quantitative assays to show a maintenance of CRU numbers, with retention of in vivo function following ex vivo culture. 相似文献